Prevention and treatment of influenza in adults
G.L. Ignatova, V.N. Antonov
South Ural State Medical University, Chelyabinsk
Annual seasonal influenza epidemics of varying severity led to significant morbidity and mortality worldwide. According to the World Health Organization, up to 646 thousand patients die from seasonal influenza every year worldwide. People get sick with the flu at any age, however, there are populations at increased risk.
This article is devoted to topical issues concerning diagnosis, treatment and prevention of influenza. The following data on risk factors for adverse outcomes and complications are presented: adults aged >65 years, pregnant women, people with certain chronic diseases, residents of nursing homes and other long-term care facilities, overweight patients, unvaccinated patients. The data on the vaccination efficacy at different age periods, as well as the recommended vaccines composition for the 2020/2021 season, are shown. In the treatment section, the main priority is given to the use of antiviral evidence-based drugs. The efficacy of domestic antiviral drug, Influcein, as well as its regimens, are considered.
Keywords: seasonal influenza, epidemic, influenza complications, antiviral drugs, vaccination.
For citation: Ignatova G.L., Antonov V.N. Prevention and treatment of influenza in adults. RMJ. 2021;3:27–30.

This work is licensed under a Creative Commons «Attribution» 4.0 License.
















